Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Recombinant Protein Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global recombinant protein market size reached US$ 151.41 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 302.88 Billion by 2027, exhibiting a growth rate (CAGR) of 11.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.

Recombinant Protein Market Trends:

The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth. Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures. Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecasted period.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant protein market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.

Breakup by Product:

  • Antibodies
  • Hormones
  • Growth Factors
  • Cytokines
  • Others
     

Breakup by Application:

  • Drug Discovery and Development
  • Academic Research
  • Biotechnology Research
  • Biopharmaceutical Production
  • Others
     

Breakup by End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organization
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global recombinant protein market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global recombinant protein market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global recombinant protein market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Recombinant Protein Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Antibodies
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Hormones
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Growth Factors
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Cytokines
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Application
    7.1    Drug Discovery and Development
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Academic Research
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Biotechnology Research
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Biopharmaceutical Production
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by End User
    8.1    Pharmaceutical and Biopharmaceutical Companies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Biotechnology Companies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Academic and Research Institutes
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Contract Research Organization
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abcam plc
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Amgen Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Bio-RAD Laboratories Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Bio-Techne Corporation
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    Bps Bioscience Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Enzo Biochem Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Genscript Biotech Corporation
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Merck KGaA
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Novo Nordisk A/S
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    ProSpec-Tany TechnoGene Ltd
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
        14.3.11    Sanofi S.A.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Thermo Fisher Scientific
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Recombinant Protein Market: Major Drivers and Challenges
Figure 2: Global: Recombinant Protein Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Recombinant Protein Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Recombinant Protein Market: Breakup by Product (in %), 2021
Figure 5: Global: Recombinant Protein Market: Breakup by Application (in %), 2021
Figure 6: Global: Recombinant Protein Market: Breakup by End User (in %), 2021
Figure 7: Global: Recombinant Protein Market: Breakup by Region (in %), 2021
Figure 8: Global: Recombinant Protein (Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Recombinant Protein (Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Recombinant Protein (Hormones) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Recombinant Protein (Hormones) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Recombinant Protein (Growth Factors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Recombinant Protein (Growth Factors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Recombinant Protein (Cytokines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Recombinant Protein (Cytokines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Recombinant Protein (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Recombinant Protein (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Recombinant Protein (Drug Discovery and Development) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Recombinant Protein (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Recombinant Protein (Academic Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Recombinant Protein (Academic Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Recombinant Protein (Biotechnology Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Recombinant Protein (Biotechnology Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Recombinant Protein (Biopharmaceutical Production) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Recombinant Protein (Biopharmaceutical Production) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Recombinant Protein (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Recombinant Protein (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Recombinant Protein (Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Recombinant Protein (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Recombinant Protein (Academic and Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Recombinant Protein (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Recombinant Protein (Contract Research Organization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Recombinant Protein (Contract Research Organization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Recombinant Protein (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Recombinant Protein (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: North America: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: North America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: United States: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: United States: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Canada: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Canada: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Asia-Pacific: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Asia-Pacific: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: China: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: China: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Japan: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Japan: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: India: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: India: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: South Korea: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: South Korea: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Australia: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Australia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Indonesia: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Indonesia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Others: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Europe: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Europe: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Germany: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Germany: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: France: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: France: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: United Kingdom: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: United Kingdom: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Italy: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Italy: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Spain: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Spain: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Russia: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Russia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Latin America: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Latin America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Brazil: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Brazil: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Mexico: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Mexico: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Others: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Middle East and Africa: Recombinant Protein Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Middle East and Africa: Recombinant Protein Market: Breakup by Country (in %), 2021
Figure 86: Middle East and Africa: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Global: Recombinant Protein Industry: SWOT Analysis
Figure 88: Global: Recombinant Protein Industry: Value Chain Analysis
Figure 89: Global: Recombinant Protein Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Recombinant Protein Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Recombinant Protein Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Recombinant Protein Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Recombinant Protein Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Recombinant Protein Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Recombinant Protein Market: Competitive Structure
Table 7: Global: Recombinant Protein Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links